After AstraZeneca temporarily halted vaccine trials, WHO said this was not uncommon. This said the WHO statement from AstraZeneca on the temporary suspension of the vaccine study

New Delhi: The World Health Organization (WHO) announced on Wednesday that the “temporary suspension” of the COVID-19 vaccine study, which is being carried out concurrently by AstraZeneca and Oxford University, is not uncommon. The announcement comes after reports that a person developed a disease from a vaccine study. However, what kind of malaise was not reported to this person.

The WHO has also determined that the safety of vaccines is of paramount importance in clinical trials and that it is common for each participant to be suspended to determine the cause of an unexplained disease.

Read also: Foreign Ministers of Russia, India, China in Moscow: Chinese Foreign Ministry

Let us know that AstraZeneca canceled global trials of its potential coronavirus vaccine on Wednesday. This has caused the shares of this UK drug maker to decline. The chances of his vaccine coming to market soon have also diminished. WHO said, “We are pleased to see that vaccine developers are very aware of the studies. You follow the standard vaccine development guidelines and rules with the utmost sincerity.

The organization has also called for “strict adherence to all protocols for the protection of the volunteers and the effectiveness of the vaccine”.

This epidemic is not the last

World Health Organization head Tedros Edholm Ghebriasis said Monday the world must prepare for another pandemic. Not only that, the preparation should be better this time around. He also urged all countries to invest in public health.

During a press conference in Geneva, Tedros said: “This will not be the last pandemic. History teaches us that outbreaks and pandemics are a part of life. Whenever the next pandemic comes, the world should be ready. Be better prepared than this time.

Regarding the vaccination, the World Health Organization announced on Friday that it did not expect widespread vaccination against covid-19 until the middle of next year. He believes that rigorous research into the efficacy and safety of any potential vaccine is important. WHO spokeswoman Margaret Harris said, “We don’t really expect widespread vaccination until the middle of next year.”